Evidence map›Paper›PMID 29379085›Full record

ArticleScientific reports2018

Efficient strategy for introducing large and multiple changes in plasmid DNA.

Fanli Zeng, Suhua Zhang, Zhimin Hao, Shixin Duan, Yanan Meng, Pan Li, Jingao Dong, Yibin Lin

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Science immunology · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits.medRxiv : the preprint server for health sciences · 2020
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fanli ZengCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China.
Suhua ZhangInstitute of Biophysics, Hebei University of Technology, Tianjin, 300401, China.
Zhimin HaoCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China.
Shixin DuanCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China.
Yanan MengCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China.
Pan LiCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China.
Jingao DongCollege of Life Sciences, Hebei Agricultural University, Baoding, 071001, China. shmdjg@hebau.edu.cn.
Yibin LinDepartment of Biochemistry and Molecular Biology, University of Texas Health Science Center at Houston McGovern Medical School, 6431 Fannin Street, Houston, TX, 77030, USA. Yibin.lin@uth.tmc.edu.ORCID http://orcid.org/0000-0003-0608-7875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While the QuikChange site-directed mutagenesis method and its later modifications are extremely useful and simple, they suffer from several drawbacks. Here, we propose a new method, named LFEAP mutagenesis (Ligation of Fragment Ends After PCR) for creating various mutations in plasmid by leveraging three existing concepts: inverse PCR, single primer PCR, and sticky-end assembly. The first inverse PCR on the target plasmid yielded linearized DNA fragments with mutagenic ends, and a second single primer PCR resulted in complementary single-stranded DNA fragments with the addition of overhangs at the 5' end of each strand. The resulting single strands were then annealed to produce double-stranded DNA with free 5' single-stranded DNA tails. These products with compatible sticky ends were efficiently assembled into a circular, mutagenized plasmid. With this strategy, multiple simultaneous changes (up to 15) and mutations in large plasmids (up to 50 kb) were achieved with high efficiency and fidelity. LFEAP mutagenesis is a versatile method that offers significant advantages for introducing large and multiple changes in plasmid DNA.

Indexed as

PlasmidsRecombination, GeneticDNAMolecular BiologyPolymerase Chain ReactionDNA

Identifiers

PMID29379085
PMCPMC5789069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.